Pharmacists in Loma Linda, CA Accepting Medicare
207 Pharmacists found. Showing 201 - 207
 Tracey Ping Le Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton Street, Loma Linda, CA 92357 Phone: 909-825-7084 |
 Dr. Phillip Hivale, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 11227 San Mateo Dr Apt A, Loma Linda, CA 92354 Phone: 817-797-1254 |
Dr. Aileen Nati Ludesirishoti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 |
Dr. Tanya Lengvilas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 |
Jennifer Vu, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25455 Barton Rd Ste 111a, Loma Linda, CA 92354 Phone: 909-558-6447 Fax: 909-558-6155 |
Samineh Sam, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 702-265-7483 |
Harry Chen, PHARM.D. Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton Street, Va Loma Linda Healthcare System (119), Loma Linda, CA 92357 Phone: 909-825-7084 |
News Archive
'Teachable moments' can reduce cancer risk in children of parents with mutations in tumor suppressor genes
Parents found to be carriers of a mutated form of the tumor suppressor genes known as BRCA1 and BRCA2 do not always share these test results with their children, but they may choose to discuss related information important to their own health with them. That is the result of a study conducted by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues, whose findings suggest that those parents are using the discovery of their mutation status as an opportunity for a "teachable moment" in educating their offspring about cancer risk reduction.
ICA reports a year full of achievements
ICA announced today that 2011 saw strong growth in hospitals and clinics under contract for its CareAlign Solutions suite, as well as significant product upgrades among its current client base. In addition, ICA's employee base again nearly doubled in 2011 to meet growing demand and critical partnerships were formalized.
Researchers discover new stem cell in the adult brain
Researchers at Lund University in Sweden have discovered a new stem cell in the adult brain. These cells can proliferate and form several different cell types - most importantly, they can form new brain cells. Scientists hope to take advantage of the finding to develop methods to heal and repair disease and injury in the brain.
FDA approves Mallinckrodt's EXALGO (32 mg) sNDA to manage opioid-related pain
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
Complement dysregulation underpins pre-eclampsia
Pre-eclampsia is associated with increased classical pathway activation and altered complement regulation, suggest Dutch results indicating that the extent of complement dysregulation may be related to the severity of pre-eclampsia.
› Verified 8 days ago
Dentists
Pharmacists
Clinical Social Workers
Psychologists
Counselors